Navigation Links
ChromaDex Announces Financial Results for Second Quarter 2011
Date:8/11/2011

IRVINE, Calif., Aug. 11, 2011 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced financial results for the second quarter of 2011. On a reported basis and calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced total revenues of approximately $1.9 million and a net loss attributable to common stockholders of $0.03 per share for the three-month period ended July 2, 2011. As of July 2, 2011, cash, cash equivalents, and marketable securities totaled over $2.0 million.

"We made substantial strides related to pTeroPure in the recent quarter, continuing to build a very strong foundation for the business expansion that is underway," stated Frank Jaksch, CEO and co-founder of ChromaDex. "Our results for the quarter did not yet reflect the business building accomplishments we achieved during the period, but we believe the foundation created, with pTeroPure achieving GRAS (generally recognized as safe) status, the upcoming launch of BluScience at GNC, as well as our licensing agreement with beverage industry giant Cott, places ChromaDex in a very strong position from which to grow long-term shareholder value. Beyond pTeroPure, we remain committed to growing our product and service offerings to include other novel ingredients with large market potential in the rapidly growing natural products industry. The recently announced in-license of intellectual property from Cornell, related to the unique Nicotinamide Riboside compound, is evidence of that continued focus."

Additional Financial Results & NotesOn a reported basis, ChromaDex recorded revenue of $1,937,976 during the second quarter of 2011 as compared to $2,033,861 for the same period in 2010. The net loss attributable to common stockhold
'/>"/>

SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
2. ChromaDex and Bruker Optics Sign Agreement to Expedite Dietary Supplement Testing for Compliance With FDA Good Manufacturing Practice Requirements
3. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
4. Life Extension® Launches New Product Containing ChromaDexs pTeroPure® Pterostilbene
5. ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/2/2015)... 3, 2015 Pharma Major ... de participación en ZAO "Biocom" en Rusia bajo ... incursión de Lupin en el mercado farmacéutico de ... ventas, colocándolo como uno de los 10 principales ... Durante más de una década, el mercado farmacéutico ...
(Date:7/2/2015)...  New product launches are critical events for the ... thought leaders about new products, Medical Affairs is one ... a new therapy performs at launch. ... leader Best Practices, LLC, critical aspects of launch support ... early stage thought leader (TL) interaction, successful TL targeting, ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
(Date:7/3/2015)... , ... July 03, 2015 ... ... the sessions and speaker lineup for its 2015 Annual Conference , ... August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national president recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency ... named Mariah N. Manzanares, MD as the new Medical Director of its Frisco facility. ... director of our Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:7/3/2015)... ... ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... community with free fitness training and indoor fitness boot camp classes for 24 straight ... thousands of charity dollars and ended with a $10,000 donation to the Jumpstart organization. ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... 10 Winners of the 2007,Award for Excellence in Human ... and Founder of the Health Improvement,Institute., Winners were: ... Online Clinical Trials Principal Investigator Self ... to educate the University,s researchers on the mechanisms by ...
... ALEXANDRIA, Va., Dec. 10 Sen. Max Baucus,(D-Mont.), ... directly,with House leadership on a must-pass Medicare bill ... in his committee last week,but with Congress, scheduled ... Rep. Charles Rangel (D-N.Y.), chair of the House ...
... lymphoma patients with a milder chemotherapy regimen before they ... resulted in long-term complete remission for 45 of 47 ... of Texas M. D. Anderson Cancer Center report at ... Hematology. , The two patients who had relapsed ...
... - Living longer with obesity can lead to both ... hospital, according to two new studies from Purdue University. ... that cite the problems of obesity," said Ken Ferraro, ... which people become obese continues to get younger, we ...
... new treatments, researchers say , , MONDAY, Dec. 10 (HealthDay ... the cancer-susceptibility gene called BRCA1 can cause some breast ... to 20 percent of all breast cancers. BBCs generally ... are almost always associated with hereditary mutations in the ...
... Clinic researchers today presented results of a phase ... first step therapy designed to reduce cancer cells ... showing an improved response over the traditional lenalidomide-dexamethasone ... B. Reeder, M.D., at the American Society of ...
Cached Medicine News:Health News:2007 Human Research Protection Award Recipients Announced 2Health News:NCPA Statement Urging Congress to Include Pharmacy Provisions in Medicare-Medicaid Legislation 2Health News:Gentler chemotherapy before stem cell transplant causes long-term remission of follicular lymphoma 2Health News:Living longer with obesity means heavier burden for hospitals 2Health News:Living longer with obesity means heavier burden for hospitals 3Health News:Mutated Suppressor Gene Leads to a Type of Breast Cancer 2Health News:Mutated Suppressor Gene Leads to a Type of Breast Cancer 3
... A to Z Drug Facts produced ... information on thousands of medications. It ... side effect, drug interactions, patient information ... drug reference for physicians, students, residents, ...
... of current natural product information ... with A to Z Drug ... checking. Includes free updates for ... ideal drug reference for physicians, ...
Instant access to drug-drug and drug-food interaction between thousands of brand and generic drugs plus A to Z Drug Facts monographs. Includes free updates for one year....
... Interaction Principles is the number one polypharmacy ... An understanding of drug interactions has become ... publication of the first edition of this ... - coupled with prolonged human life spans ...
Medicine Products: